(Bristol-Myers Squibb Company) – As the company’s biological safety officer, Dave oversees animal care and use, water reduction, process safety management and reductions of greenhouse gas emissions and excess energy. Since 2004, he has helped the site receive certification from the Wildlife Habitat Council.
A self-described “number monkey,” Doug’s work in data modeling has been an essential component of Merck’s legislative strategy. Doug is committed to ensuring the government affairs team is always equipped with data to guide and advance their advocacy efforts. His recent work on drug pricing reform echoes his ability to supply complex guidance in a
Pedro works in Public Affairs for Johnson & Johnson and had quite the year in 2017. In his role, he has helped create a more favorable climate for companies to invest and create jobs in Puerto Rico. Following the devastating effects of hurricane Maria, Pedro worked to ensure that patients could access critical medications and
(Pfizer) – Dr. Brabham is a strong advocate for Pfizer’s grassroots and PAC programs. She volunteers for Project 351, an initiative created by Massachusetts Governor Deval Patrick to, “unite diverse 8th grade service Ambassadors from every city and town in the Commonwealth for an inspirational year of community service, leadership development and enrichment.”
In 2020, Dr. Dent was a key voice in discussing the importance of biomarkers for Alzheimer’s disease with members of Congress. She participated in Capitol Hill briefings and attended multiple meetings with legislators to explain the issue. She is a powerful advocate for pioneering innovation and continues to be a trusted advisor and partner to
As a specialist in cell therapy, Victoria has played a vital role in engaging policymakers at every level of government including state and federal “fly-ins” hosted by PhRMA. BMS’s Policy, Government Affairs, and Advocacy team is continually impressed by her thoughtful approach to educating and advocating for medical innovation, like CAR T.
Kim is an individual who is committed to helping educate policymakers and stakeholders about the important and challenging work of developing new medicines for patients. She participates in several fly-ins and she’s UCB’s leading voice on the importance of diversity in clinical trials and is leading work to advance the company in this area. Her
(Eli Lilly and Company) – Jackie has worked tirelessly to ensure the right voices are heard and the right information is seen by Indiana lawmakers and has encouraged the right level of access for patients and protections that ensure a successful environment for medical innovators in the state, while also finding data that proves how
Marci has raised awareness of women’s health needs and research efforts at Astellas to treat them. She has discussed the stigma around talking about menopause and other aspects of women’s health. At the same time, Marci joined researchers from companies around the country to meet with members of Congress and their staff to discuss their
(Bayer) – Dr. Zampaglione is passionate about ensuring all women have access to the information and support they need to take control of their health. He is a champion of Bayer’s support of patient education on family planning through advocacy partnerships.